Category: Sectorial: Health Technology

Oryzon went through the confessional this Monday. The biotech company has declared losses of 3.4 million euros in 2020, a figure that represents a reduction of 7.7% compared to the same period of the previous year. The company has…

For the next few days it seems very likely that we could end up seeing an extension of the gains in the selective Spanish to the level of 9,000 points. With this very favorable outlook on the Ibex 35, we have selected three stocks that…

It is important that the Spanish selective does not abandon the support of 8,000 pointsTechnical analysisBREAKING RESISTANCE Rovi Laboratories it has managed to pierce the resistance of 43.8 euros, which allows it to move…

Oryzon Genomics It rises 10.28% which allows it to pierce the resistance of 2,875 euros. Be aware that we could end up seeing an extension of the rises to the level of 3.20 euros. Let us advise you on your investments. Try Trader Watch…

The most normal thing is that it continues to gain positionsTechnical analysisSECURITIES IN A BULL TREND The increases in recent days bring the price of Johnson & Johnson to the top of the lateral movement in which the…

Below the first level of support in the selective Spanish is at 6,763 pointsTechnical analysisBREAKING RESISTANCE Attentive to the end of the lateral consolidation of the last sessions in Rovi. The company rises 4.82% which…

Moderna's vaccine schedule continues its course. Rovi has confirmed this Tuesday that it will start manufacturing millions of doses for the American company from the beginning of 2021: "Fortunately, Moderna's vaccine…

Vertex Pharma has collapsed after dropping a trial against protein deficiency that was intended to compete with the products of Grifols based on human blood plasma.The actions of Vertex they are down 20.70% on Wall Street, to $ 240,…

At the moment the Spanish selective offers a complicated technical aspectTechnical analysisBREAKING RESISTANCE Outstanding 25.85% gains in ACS that manages to pulverize the short-term resistance that it presents at 22.33…

--EXPANDING--AstraZeneca weekly chart.